The polymorphism of the β3-adrenergic receptor gene is associated with reduced low-density lipoprotein particle size

Metabolism: Clinical and Experimental

Volumn 52, Issue 3, 2003, Pages 356-361

  Okumura, Kenji ^a   Matsui, Hideo ^a   Ogawa, Yasuhiro ^a   Takahashi, Ryotaro ^a   Matsubara, Kenichiro ^a   Imai, Hajime ^a   Imamura, Akiko ^a   Mizuno, Tomofumi ^a   Tsuzuki, Michitaka ^a   Kitamura, Yoko ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; BETA 3 ADRENERGIC RECEPTOR; GLYCOSYLATED HEMOGLOBIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; ARGININE; BIOCHEMICAL MARKER; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POLYACRYLAMIDE GEL; TRYPTOPHAN;

ADULT; AGED; ALLELE; ARTICLE; BLOOD; BODY MASS; CHEMISTRY; CORONARY ARTERY DISEASE; DIET RESTRICTION; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; MIDDLE AGED; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; REGRESSION ANALYSIS; RISK FACTOR; ABDOMEN; ATHEROSCLEROSIS; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG EXPOSURE; EXPERIMENTAL MODEL; GENETIC VARIABILITY; HEREDITY; HIGH RISK PATIENT; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; JAPAN; MEDICAL ASSESSMENT; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR GENE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ALLELES; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BLOOD GLUCOSE; BODY MASS INDEX; CORONARY DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FASTING; FEMALE; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; REGRESSION ANALYSIS; RISK FACTORS; TRIGLYCERIDES;

EID: 0037362537     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2003.50056     Document Type: Article

References (49)

1. Castelli WP, Garrison RJ, Wilson PWF, et al: Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 256:2835-2838, 1986
2. Shen MMS, Krauss RM, Lindgren FT, et al: Heterogeneity of serum low density lipoprotein in normal human subjects. J Lipid Res 22:236-244, 1981
3. Gambert P, Bouzerand-Gambert C, Athias A, et al: Human low density lipoprotein subfractions separated by gradient gel electrophoresis: Composition, distribution, and alterations induced by cholestryl ester transfer protein. J Lipid Res 31:1199-1210, 1990
4. Austin MA, Breslow JL, Hennekens CH, et al: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 260:1917-1921, 1988
5. Crouse JR, Parks JS, Schey HM: Studies of low density lipoprotein molecular weight in human beings with coronary artery disease. J Lipid Res 26:566-574, 1985
6. Haffner SM, Mykkänen L, Stern MP, et al: Greater effect of diabetes on LDL size in women than in men. Diabetes Care 17:1164-1171, 1994
7. Singh ATK, Rainwater DL, Haffner SM, et al: Effect of diabetes on lipoprotein size. Arterioscler Thromb Vasc Biol 15:1805-1811, 1995
8. Williams PT, Krauss RM: Associations of age, adiposity, menopause, and alcohol intake with low-density lipoprotein subclasses. Arterioscler Thromb Vasc Biol 17:1082-1090, 1997
9. Reaven GM, Chen YD, Jeppesen J, et al: Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92:141-146, 1993
10. McNamara JR, Jenner JL, Li Z, et al: Change in LDL particle size is associated with change in plasma triglyceride concentration. Arterioscler Thromb 12:1284-1290, 1992
11. Okumura K, Matsui H, Kawakami K, et al: Low density lipoprotein particle size is associated with glycosylated hemoglobin levels regardless of plasma lipid levels. Intern Med 37:273-279, 1998
12. Austin MA, King MC, Vranizan KM, et al: Inheritance of low-density lipoprotein subclass patterns: Results of complex segregation analysis. Am J Hum Genet 43:838-846, 1988
13. Austin MA, Brunzell JD, Fitch WL, et al: Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 10:520-530, 1990
14. Selby JV, Austin MA, Newman B, et al: LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88: 381-387, 1993
15. Caro JF: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab 73:691-695, 1991
16. Pouliot MC, Desprès J-P, Nadeau A, et al: Visceral obesity in men: Associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 41:826-834, 1992
17. 3-adrenergic-receptor gene. N Engl J Med 333:343-347, 1995
18. Carvalho E, Jansson PA, Axelsen M, et al: Low cellular IRS 1 gene and protein expression predict insulin resistance and NIDDM. FASEB J 13:2173-2178, 1999
19. Beamer BA, Yen CJ, Andersen RE, et al: Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-γ2 gene with obesity in two Caucasian populations. Diabetes 47:1806-1808, 1998
20. Baier LJ, Sacchettini JC, Knowler WC, et al: An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95:1281-1287, 1995
21. 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351, 1995
22. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 23:97-104, 1982
23. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
24. Matthews DR, Hosker JP, Rudenski AS, et al: Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985.
25. 3-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 24:1579-1583, 2001
26. Okumura K, Matsui H, Kawakami K, et al: Relationship between the apolipoprotein E and angiotensin-converting enzyme genotypes and LDL particle size in Japanese subjects. Clin Chim Acta 285:91-103, 1999
27. Okumura K, Matsui H, Kamiya H, et al: Differential effect of two common polymorphisms in the cholesteryl ester transfer protein gene on low-density lipoprotein particle size. Atherosclerosis 161:425-431, 2002
28. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349, 1993
29. 3-adrenoreceptors in obesity. J Clin Invest 95:1109-1116, 1995
30. Shuldiner AR, Sabra M: Trp64Arg β3-Adrenoceptor: When does a candidate gene become a disease-susceptibility gene? Obes Res 9:806-809, 2001
31. 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women: Effects on weight, BMI, abdominal fat, blood pressure and reproductive history in an elderly Australian population. Diabetes 45:1358-1363, 1996
32. 3-adrenergic receptor and peroxisome proliferator-activated receptor-γ2 genes and obesity. Diabetes Care 24:672-677, 2001
33. 3-adrenoceptor gene to central adiposity and high blood pressure: Interaction with age. Cross sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 19:399-406, 2001
34. 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 215:555-560, 1995
35. Camejo G, Hurt-Camejo E, Bondiers G: Effect of proteoglycans on lipoprotein-cell interactions: Possible contribution to atherogenesis. Curr Opin Lipidol 1:431-436, 1990
36. Bioletto S, Fontana P, Darioli R, et al: Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; An influence of the E4 allele on large (Sf>60) particles. Atherosclerosis 138:207-215, 1998
37. Tribble DL, Holl LG, Wood PD, et al: Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size. Atherosclerosis 93:189-199, 1992
38. Beard CM, Barnard RJ, Robbins DC, et al: Effects of diet and exercise on qualitative and quantitative measures of LDL and its susceptibility to oxidation. Arterioscler Thromb Vasc Biol 16:201-207, 1996
39. Tanaga K, Bujo H, Inoue M, et al: Increased circulating malondialdehyde-modified LDL levels in patients with coronary artery diseases and their association with peak sizes of LDL particles. Arterioscler Thromb Vasc Biol 22:662-666, 2002
40. Mykkänen L, Haffner SM, Rainwater DL, et al: Relationship of LDL size to insulin sensitivity in normoglycemic men. Arterioscler Thromb Vasc Biol 17:1447-1453, 1997
41. Slyper AH, Zvereva S, Schectman G, et al: Insulin resistance is not a major determinant of low density lipoprotein particle size. Metabolism 46:1275-1280, 1997
42. Katzel LI, Coon PJ, Rogus E, et al: Persistence of low HDL-C levels after weight reduction in older men with small LDL particles. Arterioscler Thromb Vasc Biol 15:299-305, 1995
43. 3-adrenergic agonists in transfected 3T3-L1 preadipocytes. Horm Metab Res 32:91-96, 2000
44. 1-adrenergic receptors in adipose tissue of congenitally obese (C57BL/6J ob/ob) mice. Mol Endocrinol 8:518-527, 1994
45. Arner P: Catecholamine-induced lipolysis in obesity. Int J Obes Relat Metab Disord 23:10S-13S, 1999
46. Lönnqvist F, Thörne A, Large V, et al: Sex differences in visceral fat lipolysis and metabolic complications of obesity. Arterioscler Thromb Vasc Biol 17:1472-1480, 1997
47. Ikeda T, Gomi T, Hirawa N, et al: Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension 27:1180-1186, 1996
48. Westerbacka J, Yki-Järvinen H, Turpeinen A, et al: Inhibition of platelet-collagen interaction: An in vivo action of insulin abolished by insulin resistance in obesity. Arterioscler Thromb Vasc Biol 22:167-172, 2002
49. Nakajima K, Hinman J, Pfaffinger D, et al: Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of LDL independently of apolipoprotein(a) size. Arterioscler Thromb Vasc Biol 21:1238-1243, 2001